| Year |
Citation |
Score |
| 2019 |
Lenz HJ, Ou FS, Venook AP, Hochster HS, Niedzwiecki D, Goldberg RM, Mayer RJ, Bertagnolli MM, Blanke CD, Zemla T, Qu X, Wirapati P, Tejpar S, Innocenti F, Kabbarah O. Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1802258. PMID 31042420 DOI: 10.1200/JCO.18.02258 |
0.311 |
|
| 2019 |
Piskol R, Huw LY, Sergin I, Kim D, Kljavin NM, Tam R, Patel R, Burton J, Penuel E, Qu X, Koeppen H, Sumiyoshi T, de Sauvage FJ, Lackner MR, de Sousa E Melo F, ... Kabbarah O, et al. A Clinical Applicable Gene Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31004000 DOI: 10.1158/1078-0432.Ccr-18-3032 |
0.306 |
|
| 2019 |
Innocenti F, Ou FS, Qu X, Zemla TJ, Niedzwiecki D, Tam R, Mahajan S, Goldberg RM, Bertagnolli MM, Blanke CD, Sanoff H, Atkins J, Polite B, Venook AP, Lenz HJ, ... Kabbarah O, et al. Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801798. PMID 30865548 DOI: 10.1200/JCO.18.01798 |
0.312 |
|
| 2019 |
Wirapati P, Qu X, Huw L, Etlioglu E, Tejpar S, Kabbarah O. Prognostic stromal and immune response expression patterns in early-stage colorectal cancer predicted by genes intrinsically expressed by tumor epithelial cells. Journal of Clinical Oncology. 37: 3601-3601. DOI: 10.1200/JCO.2019.37.15_SUPPL.3601 |
0.302 |
|
| 2016 |
Kim D, Choi Y, Ireland J, Foreman O, Tam RN, Patel R, Schleifman EB, Motlhabi M, French D, Wong CV, Peters E, Molinero L, Raja R, Amler LC, Hampton GM, ... ... Kabbarah O, et al. Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers. Plos One. 11: e0165856. PMID 27846280 DOI: 10.1371/Journal.Pone.0165856 |
0.319 |
|
| 2016 |
Qu X, Sandmann T, Frierson H, Fu L, Fuentes E, Walter K, Okrah K, Rumpel C, Moskaluk C, Lu S, Wang Y, Bourgon R, Penuel E, Pirzkall A, Amler L, ... ... Kabbarah O, et al. Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter. Oncogene. PMID 27270421 DOI: 10.1038/onc.2016.170 |
0.365 |
|
| 2006 |
Kabbarah O, Mallon MA, Pfeifer JD, Goodfellow PJ. Transcriptional profiling endometrial carcinomas microdissected from DES-treated mice identifies changes in gene expression associated with estrogenic tumor promotion. International Journal of Cancer. Journal International Du Cancer. 119: 1843-9. PMID 16804899 DOI: 10.1002/Ijc.22063 |
0.591 |
|
| 2005 |
Kabbarah O, Sotelo AK, Mallon MA, Winkeler EL, Fan MY, Pfeifer JD, Shibata D, Gutmann DH, Goodfellow PJ. Diethylstilbestrol effects and lymphomagenesis in Mlh1-deficient mice. International Journal of Cancer. Journal International Du Cancer. 115: 666-9. PMID 15700306 DOI: 10.1002/Ijc.20918 |
0.571 |
|
| 2003 |
Kabbarah O, Mallon MA, Pfeifer JD, Edelmann W, Kucherlapati R, Goodfellow PJ. A panel of repeat markers for detection of microsatellite instability in murine tumors. Molecular Carcinogenesis. 38: 155-9. PMID 14639654 DOI: 10.1002/Mc.10157 |
0.565 |
|
| 2003 |
Gutmann DH, Winkeler E, Kabbarah O, Hedrick N, Dudley S, Goodfellow PJ, Liskay RM. Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. Oncogene. 22: 4581-5. PMID 12881715 DOI: 10.1038/Sj.Onc.1206768 |
0.542 |
|
| 2003 |
Kabbarah O, Pinto K, Mutch DG, Goodfellow PJ. Expression profiling of mouse endometrial cancers microdissected from ethanol-fixed, paraffin-embedded tissues. The American Journal of Pathology. 162: 755-62. PMID 12598310 DOI: 10.1016/S0002-9440(10)63872-2 |
0.506 |
|
| Show low-probability matches. |